The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
On the final day of INVEST Precision Medicine, a panel with Caris Health, CVS Health, and Intermountain Healthcare will share assessments of precision medicine's progress and the outlook for this sector. Also, a panel will highlight non dilutive funding opportunities for startups. Register now!
The conference will include conversations with healthcare industry experts from The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Vineti, Ori Biotech, CVS Caremark, Caris Life Sciences, HHS, University City Science Center, and more.
Ellen Weber, who heads up angel investment group Robin Hood Ventures, has been named as the new head of Temple University’s Innovation and Entrepreneurship Institute as part of its business school, according to a statement from the university. She will also head up angel investor group Mid Atlantic Diamond Ventures, which is run out of […]
A university is offering early stage companies from its academic community office space in an incubator as the institution doubles its technology transfer office staff. Philadelphia-based Temple University has opened an office in the University City Science Center that serves as an incubator for many life science and technology companies. So far, it is negotiating […]
Temple University’s Moulder Center for Drug Discovery Research in Philadelphia, Pennsylvania has formed a collaboration with India-based GVK Biosciences to identify biomarkers. GVK Bio will be responsible for the target validation, lead identification and lead optimization of small molecules in selected therapeutic areas, including cardiovascular, metabolic and central nervous system disorders. The Moulder Center, opened […]
